|
Volumn 76, Issue 2, 1990, Pages 295-300
|
Long‐term trial with the oral iron chelator 1,2‐dimethyl‐3‐hydroxypyrid‐4‐one (L1) I. IRON CHELATION AND METABOLIC STUDIES
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
DEFERIPRONE;
ARTICLE;
CLINICAL ARTICLE;
HUMAN;
HUMAN EXPERIMENT;
IRON CHELATION;
IRON OVERLOAD;
MYELODYSPLASIA;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
THALASSEMIA;
ANEMIA;
BLOOD TRANSFUSION;
FERRITIN;
HALF-LIFE;
HUMAN;
IRON;
IRON CHELATING AGENTS;
MYELODYSPLASTIC SYNDROMES;
PYRIDONES;
SUPPORT, NON-U.S. GOV'T;
THALASSEMIA;
|
EID: 0025018222
PISSN: 00071048
EISSN: 13652141
Source Type: Journal
DOI: 10.1111/j.1365-2141.1990.tb07887.x Document Type: Article |
Times cited : (121)
|
References (29)
|